Economics of dementia: A review of methods

被引:12
作者
Connolly, Sheelah [1 ]
机构
[1] Econ & Social Res Inst, Whitaker Sq, Dublin 2, Ireland
来源
DEMENTIA-INTERNATIONAL JOURNAL OF SOCIAL RESEARCH AND PRACTICE | 2020年 / 19卷 / 05期
关键词
economic methods; cost-of-illness; economic evaluation; cost; valuing caregiving; COST-OF-ILLNESS; COGNITIVE STIMULATION THERAPY; ALZHEIMERS-DISEASE; INFORMAL CARE; PEOPLE; LIFE; EQ-5D; SUPPORT; UTILITY; BURDEN;
D O I
10.1177/1471301218800639
中图分类号
R4 [临床医学]; R592 [老年病学];
学科分类号
1002 ; 100203 ; 100602 ;
摘要
Given the expected increase in the number of people with dementia in the coming years, it is anticipated that the resources necessary to support those with dementia will significantly increase. There will therefore likely be increased emphasis on how best to use limited resources across a number of domains including prevention, diagnosis, treatment and supporting informal caregivers. There has been increasing use of economic methods in dementia in the past number of years, in particular, cost-of-illness analysis and economic evaluation. This paper reviews the aforementioned methods and identities a number of methodological issues that require development. Addressing these methodological issues will enhance the quality of economic analysis in dementia and provide some useful insights about the best use of limited resources for dementia.
引用
收藏
页码:1426 / 1440
页数:15
相关论文
共 67 条
  • [1] Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study
    Ahmadi-Abhari, Sara
    Guzman-Castillo, Maria
    Bandosz, Piotr
    Shipley, Martin J.
    Muniz-Terrera, Graciela
    Singh-Manoux, Archana
    Kivimaki, Mika
    Steptoe, Andrew
    Capewell, Simon
    O'Flaherty, Martin
    Brunner, Eric J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2017, 358
  • [2] Cost-of-illness studies - A review of current methods
    Akobundu, Ebere
    Ju, Jing
    Blatt, Lisa
    Mullins, C. Daniel
    [J]. PHARMACOECONOMICS, 2006, 24 (09) : 869 - 890
  • [3] Socio-economic burden of rare diseases: A systematic review of cost of illness evidence
    Angelis, Aris
    Tordrup, David
    Kanavos, Panos
    [J]. HEALTH POLICY, 2015, 119 (07) : 964 - 979
  • [4] Use of the EQ-5D among patients suffering from dementia
    Ankri, J
    Beaufils, B
    Novella, JL
    Morrone, I
    Guillemin, F
    Jolly, D
    Ploton, L
    Blanchard, F
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (11) : 1055 - 1063
  • [5] [Anonymous], 2010, World Alzheimer Report 2010: The Global Economic Impact of Dementia
  • [6] [Anonymous], 2002, Methods for the Economic Evaluation of Health Care Programmes
  • [7] [Anonymous], 2015, METHODS EC EVALUATI
  • [8] [Anonymous], 2011, DON GAL RIV MEM TREA
  • [9] COST OF ILLNESS STUDIES - NO AID TO DECISION-MAKING - REPLY
    BEHRENS, C
    HENKE, KD
    [J]. HEALTH POLICY, 1988, 10 (02) : 137 - 141
  • [10] Bloom D.E., 2011, PGDA Working Papers